QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

GHRS

QT70GH Research PLC
NASDAQ·Healthcare·Biotechnology·Ireland
Latest market price
22.24
+0.54+2.49%
OverviewShort InterestFilings
GHRSQT70GH Research PLC·NASDAQ
OverviewShort InterestFilings
22.24+2.49%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand68.56M
Perf Week7.65%
Market Cap1.49BForward P/E-EPS next Y-1.96Insider Trans-Shs Float-Perf Month1.37%
Enterprise Value1.25BPEG1.41EPS next Q-0.31Inst Own-Short Float-Perf Quarter50.17%
Income-62334263.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y75.67%
Sales-P/B5.11EPS next Y-38.95%ROA-20.49%Short Interest-Perf YTD75.12%
Book/sh3.06P/C-EPS next 5Y-ROE-19.83%52W High25.94 -14.26%Perf Year85.49%
Cash/sh2.30P/FCF-EPS past 3/5Y-ROIC-25.28%52W Low11.32 96.47%Perf 3Y-
Dividend Est.-EV/EBITDA-22.30Sales past 3/5Y-Gross Margin0.00%Volatility4.26% 4.89%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-22.67%Oper. Margin0.00%ATR (14)1.60Perf 10Y-
Dividend Ex-Date-Quick Ratio23.04Sales Y/Y TTM-Profit Margin0.00%RSI (14)54.57Recom2.00
Dividend Gr. 3/5Y-Current Ratio23.04EPS Q/Q-63.16%SMA200.75%Beta1.74Target Price40.57
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA506.83%Rel Volume2.11Prev Close21.70
Employees50LT Debt/Eq0.00EarningsAug 06SMA20039.34%Avg Volume258.34KPrice22.24
IPO DateJun 25, 2021Option/ShortYes / YesEPS/Sales Surpr.-14.81% -Net Debt/EBITDA4.34Volume544,569Change2.49%
Analyst Ratings
DateActionAnalystRatingTarget
May-19-26ReiteratedH.C. Wainwright$70 → $65
May-15-26ReiteratedCantor FitzgeraldOverweight$35
Mar-10-26ReiteratedGuggenheimBuy$29 → $34
Mar-06-26ReiteratedNeedhamBuy$29 → $32
Jan-23-26ReiteratedRBC CapitalOutperform$40
Jan-06-26ReiteratedWolfe Research$39
Jan-06-26ReiteratedCanaccord GenuityBuy$28 → $39
Jan-06-26ReiteratedNeedhamBuy$19 → $29
Jan-05-26ReiteratedGuggenheimBuy$29
Jan-05-26ReiteratedNeedhamBuy$19 → $29
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other221511
Research and Development393530
Other Operating Expense-100
Operating Income-61-50-41
Interest Expense011
Unusual Expense
———
Non-Operating Income (Expense)-13-11-6
Net Income Before Taxes-48-39-36
Income Taxes
000
Consolidated Net Income-48-39-36
Net Income From Continuing Operations-48-39-36
Net Income-48-39-36
EPS (Recurring)-0.79-0.75-0.68
EPS (Basic, Before Extraordinaries)-0.79-0.75-0.68
EPS (Diluted)-0.79-0.75-0.68
EBITDA-47-39-35
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding615252
Market Capitalization775——
Operating Lease Expense
———
Insider Trading Volume
$23.63$20.79$17.94$15.09$12.25● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR